Please sign in to follow a disease.
Hyperlipoproteinemia type 3
MONDO:0018473Hyperlipoproteinemia (HLP) type 3 is a rare combined hyperlipidemia characterized by high levels of cholesterol and triglycerides, transported by intermediate density lipoproteins (IDLs), and a high risk of premature atherosclerosis and cardiovascular disease.
Also known as: Broad-betalipoproteinemia, HLP type 3, dyslipidaemia type 3, dyslipidemia type 3, familial dysbetalipoproteinemia, familial hyperlipoproteinemia type 3, hyperlipidemia type 3, hyperlipoproteinemia type III
5 clinical trials for this condition and its sub-types, 4 tagged with Hyperlipoproteinemia type 3 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Last-resort drug offered to kids with deadly cholesterol condition
Disease control ApprovedThis program provides evinacumab to children with homozygous familial hypercholesterolemia (HoFH) or severe high triglycerides when standard treatments don't work. The drug helps lower dangerous fat levels in the blood, but patients must keep taking it long-term to control their …
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Hospital staff study reveals hidden heart risk?
Knowledge-focused OngoingThis study checks how common high levels of lipoprotein(a) — a genetic risk factor for heart disease — are among hospital staff and their families. About 2800 participants will give blood samples and be followed over time to see if high levels lead to more heart problems. The goa…
Sponsor: Changi General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC